257 related articles for article (PubMed ID: 32943695)
1. Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.
Löwenmark T; Löfgren-Burström A; Zingmark C; Eklöf V; Dahlberg M; Wai SN; Larsson P; Ljuslinder I; Edin S; Palmqvist R
Sci Rep; 2020 Sep; 10(1):15250. PubMed ID: 32943695
[TBL] [Abstract][Full Text] [Related]
2. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
[TBL] [Abstract][Full Text] [Related]
3. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
[TBL] [Abstract][Full Text] [Related]
4. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
[TBL] [Abstract][Full Text] [Related]
5. Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies.
Xie YH; Gao QY; Cai GX; Sun XM; Sun XM; Zou TH; Chen HM; Yu SY; Qiu YW; Gu WQ; Chen XY; Cui Y; Sun D; Liu ZJ; Cai SJ; Xu J; Chen YX; Fang JY
EBioMedicine; 2017 Nov; 25():32-40. PubMed ID: 29033369
[TBL] [Abstract][Full Text] [Related]
6. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fecal microbial markers in colorectal cancer detection.
Eklöf V; Löfgren-Burström A; Zingmark C; Edin S; Larsson P; Karling P; Alexeyev O; Rutegård J; Wikberg ML; Palmqvist R
Int J Cancer; 2017 Dec; 141(12):2528-2536. PubMed ID: 28833079
[TBL] [Abstract][Full Text] [Related]
8. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer.
Shah MS; DeSantis TZ; Weinmaier T; McMurdie PJ; Cope JL; Altrichter A; Yamal JM; Hollister EB
Gut; 2018 May; 67(5):882-891. PubMed ID: 28341746
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of faecal
Wong SH; Kwong TNY; Chow TC; Luk AKC; Dai RZW; Nakatsu G; Lam TYT; Zhang L; Wu JCY; Chan FKL; Ng SSM; Wong MCS; Ng SC; Wu WKK; Yu J; Sung JJY
Gut; 2017 Aug; 66(8):1441-1448. PubMed ID: 27797940
[TBL] [Abstract][Full Text] [Related]
10. The Role of Fecal
Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
[TBL] [Abstract][Full Text] [Related]
11. Parvimonas micra can translocate from the subgingival sulcus of the human oral cavity to colorectal adenocarcinoma.
Conde-Pérez K; Buetas E; Aja-Macaya P; Martin-De Arribas E; Iglesias-Corrás I; Trigo-Tasende N; Nasser-Ali M; Estévez LS; Rumbo-Feal S; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LA; Bou G; Mira A; Vallejo JA; Poza M
Mol Oncol; 2024 May; 18(5):1143-1173. PubMed ID: 37558206
[TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
[TBL] [Abstract][Full Text] [Related]
13. Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer.
Löwenmark T; Li X; Löfgren-Burström A; Zingmark C; Ling A; Kellgren TG; Larsson P; Ljuslinder I; Wai SN; Edin S; Palmqvist R
Cancer Immunol Immunother; 2022 Oct; 71(10):2565-2575. PubMed ID: 35301576
[TBL] [Abstract][Full Text] [Related]
14. Tumour Colonisation of
Löwenmark T; Löfgren-Burström A; Zingmark C; Ljuslinder I; Dahlberg M; Edin S; Palmqvist R
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497419
[TBL] [Abstract][Full Text] [Related]
15. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
[TBL] [Abstract][Full Text] [Related]
16. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
[TBL] [Abstract][Full Text] [Related]
17. Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers.
Malagón M; Ramió-Pujol S; Serrano M; Serra-Pagès M; Amoedo J; Oliver L; Bahí A; Mas-de-Xaxars T; Torrealba L; Gilabert P; Miquel-Cusachs JO; García-Nimo L; Saló J; Guardiola J; Piñol V; Cubiella J; Castells A; Aldeguer X; Garcia-Gil J
Aliment Pharmacol Ther; 2019 Jun; 49(11):1410-1420. PubMed ID: 31025420
[TBL] [Abstract][Full Text] [Related]
18. Analysis of
Guven DC; Dizdar O; Alp A; Akdoğan Kittana FN; Karakoc D; Hamaloglu E; Lacin S; Karakas Y; Kilickap S; Hayran M; Yalcin S
Biomark Med; 2019 Jun; 13(9):725-735. PubMed ID: 31157977
[No Abstract] [Full Text] [Related]
19. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
20. Expanding the Colorectal Cancer Biomarkers Based on the Human Gut Phageome.
Shen S; Huo D; Ma C; Jiang S; Zhang J
Microbiol Spectr; 2021 Dec; 9(3):e0009021. PubMed ID: 34935421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]